The 2022 Boao Forum of Chinese Entrepreneurs "New Era Sharing Health and New Life Photo Exhibition" was unveiled, and Yangzijiang Pharmaceutical Group displayed the layout of the big health industry

From November 25th to 28th, the "New Era Sharing Health and New Life Photo Exhibition", hosted by Xinhua News Agency and Hainan Provincial People's Government, undertaken by Xinhua News Agency National Brand Engineering Office and China Picture Group, and co-organized by Yangtze River Pharmaceutical Group, as an integral part of the 2022 Boao Forum for Chinese Entrepreneurs, was exhibited
on the corridor platform of the Boao Forum for Asia International Conference Center.

As a representative of the health industry, Yangzijiang Pharmaceutical Group fully demonstrated the unremitting efforts and outstanding achievements
made by the Group in the fields of quality and innovation since the 18th National Congress of the Communist Party of China since the 18th National Congress of the Communist Party of China.

The relevant person in charge of Yangzijiang Pharmaceutical Group said that in the new era, in the past ten years, national pharmaceutical enterprises represented by Yangzijiang Pharmaceutical have firmly grasped the development opportunities brought by the construction of "healthy China", and achieved remarkable results from imitation to creation, from quantitative change to qualitative change, and it is of special significance
to hold such a photo exhibition in this context.

As a leading enterprise of ethnic medicine, Yangzijiang Pharmaceutical Group has established 4 national R&D platforms and more than
30 innovative drugs under development.
In 2021, the first self-developed chemical innovative drug levonidazole phosphate disodium for injection was approved for marketing, achieving a "zero breakthrough" and a leap forward in independent innovation; In 2022, the famous traditional Chinese medicine formula will develop and add the heavy variety of "Spleen Cleansing Formula" to enrich the use of non-erosive reflux disease
.
At present, 124 generic drug varieties have passed or are deemed to have passed the consistency evaluation, of which 31 are the first in China, and the varieties under research form an orderly echelon with existing products
.
In addition, in the first seven batches of centralized procurement of drugs in the country, Yangzijiang Pharmaceutical Group has selected a total of 43 varieties, which meets the health needs
of patients at all stages of life.
The Group has also cooperated with Binhui and Rico Biotech to invest in the construction of Shengsen biopharmaceutical projects, explore new models of biopharmaceutical development, and accelerate the creation of a new highland
of modern biopharmaceutical industry.

In October 2021, Yangzijiang Pharmaceutical Group held the first chemical class 1 new drug - cutting-edge ® levonidazole phosphate disodium for injection
.

The exhibition also featured the remarkable results
achieved by Yangzijiang Pharmaceutical Group in quality control throughout the process.
In order to control product quality from the source, the Group has established bases of Chinese medicinal materials in 15 provinces across the country, starting from site selection, seedling breeding and field management, and carrying out strict standardized control
of harvesting, production, inspection, storage, transportation and circulation.
In order to reduce the interference of human factors and further control product quality, the Group has also taken the lead in exploring intelligent and automated production plants
for traditional Chinese medicine in the industry.
In August 2022, the industry-leading all-round intelligent inspection robot Alpha Test 1 of Chinese medicine was incubated and landed in Longfengtang Traditional Chinese Medicine Industrial Park in Yangtze River, which is the first application
of smart Chinese medicine testing technology in the traditional Chinese medicine industry.
The inspector only needs to put the sample to be tested into the equipment, click the operation panel lightly, the equipment will operate automatically, and the test results
can be directly read on the computer.

This photo shows the all-round intelligent testing robot Alpha Test 1
.

The "Healthy China" strategy calls for accelerating the shift from a treatment-centered to a health-centric approach, which requires extensive participation
by the government, the public and related industries.
Health for everyone and happiness for everyone is the call of the new era, and it is also the ardent expectation
of the people.

Under the guidance of this concept, Yangzijiang Pharmaceutical Group has accelerated the layout of the health industry and promoted the integrated development
of "medicine, medicine, health care, food and tourism".
Jiangsu Huyou Health Technology Co.
, Ltd.
, a subsidiary, has increased the development of medicinal and food homologous health care products, and has successively launched more than 20 health care varieties such as yam Guguoduo and red deer bone ammonia; Based on the field of probiotics, Jiangsu Hengkang Biotechnology Co.
, Ltd.
introduces Japanese original strains and advanced production technology, and exclusively develops ZW probiotics and their derivative products to meet the growing needs
of the masses for healthy life.

The picture shows the big health products
displayed by Yangzijiang Pharmaceutical Group at the forum.

"Without the health of the whole people, there will be no overall moderate prosperity", people's health is an important feature of China's modernization road, an important symbol of a modern socialist power, and an important content for
achieving the second centenary goal 。 In the new journey of building a modern socialist country in an all-round way, pharmaceutical enterprises shoulder new missions and new tasks, the relevant person in charge of Yangzijiang Pharmaceutical Group said, "We will focus on the grand blueprint drawn by the 20th National Congress of the Communist Party of China, continue to make efforts, never slacken, continue to adhere to the main business of medicine, fully deploy the big health industry, continue to lead industry innovation, continue to write a new chapter in the high-quality development of health and health undertakings, and let the people enjoy higher quality health and medical services"
.

Founded in 2016, the Boao Forum for Chinese Entrepreneurs has been held for seven consecutive sessions, aiming to build a platform for exchanges, promote entrepreneurship, and promote high-quality economic development, and has become an annual ideological feast
for Chinese entrepreneurs.
In addition to the opening ceremony of the main forum, the scholars' sharing session and round tables, this year's forum also included more than 40 sub-forums, Xinhua News Agency Economic Think Tank Symposium, "Sharing a Healthy New Life in the New Era" photo exhibition and other activities
.